XML 69 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 13 - Revenue by Product Group, by Significant Customer and by Geographic Region; Geographic Information
12 Months Ended
Dec. 31, 2013
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
13. Revenue by Product Group, by Significant Customer and by Geographic Region; Geographic Information

Product revenue by product group is as follows:

   
Year Ended December 31,
 
   
2013
   
2012
   
2011
 
   
Revenue
   
Percentage
of Product
Revenue
   
Revenue
   
Percentage
of Product
Revenue
   
Revenue
   
Percentage
of Product
Revenue
 
Orthobiologics
  $ 55,956,068       78 %   $ 49,954,112       74 %   $ 39,858,139       64 %
Dermal
    1,816,602       3 %     1,384,403       2 %     3,681,166       6 %
Surgical
    5,445,715       8 %     5,022,456       7 %     4,976,261       8 %
Ophthalmic
    4,656,560       6 %     8,784,011       13 %     10,963,822       18 %
Veterinary
    3,898,785       5 %     2,865,187       4 %     2,476,998       4 %
    $ 71,773,730       100 %   $ 68,010,169       100 %   $ 61,956,386       100 %

Product revenue by significant customers as a percent of product revenues is as follows:

Percentage of Product Revenue

   
Year Ended December 31,
 
   
2013
   
2012
   
2011
 
 DePuy Mitek
    63 %     61 %     47 %
 Boehringer
    5 %     4 %     4 %
 Bausch & Lomb
    5 %     12 %     16 %
 Pharmascience/Rivex
    3 %     2 %     1 %
 Medtronic XoMed
    3 %     3 %     6 %
      79 %     82 %     74 %

Total revenue by geographic location in total and as a percentage of total revenue are as follows:

   
Year Ended December 31,
 
   
2013
 
2012
 
2011
 
   
Revenue
   
Percentage
of Total
Revenue
 
Revenue
   
Percentage
of Total
Revenue
 
Revenue
   
Percentage
of Total
Revenue
 
United States
  $ 58,490,142       78 %   $ 57,976,667       81 %   $ 48,366,140       75 %
Europe
    7,411,568       10 %     6,218,890       9 %     10,988,664       17 %
Other
    9,179,444       12 %     7,162,948       10 %     5,423,831       8 %
Total
  $ 75,081,154       100 %   $ 71,358,505       100 %   $ 64,778,635       100 %

The Company recorded licensing, milestone and contract revenue of $3,307,424, $3,348,336 and $2,822,249 for the years ended December 31, 2013, 2012, and 2011, respectively. Substantially all licensing, milestone and contract revenue was derived in the United States for each year presented.

Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid.

Net tangible long-lived assets by principal geographic areas were as follows:

   
Years Ended December 31,
 
   
2013
   
2012
 
United States
  $ 31,999,468     $ 33,792,325  
Italy
    939,243       1,320,656  
Total
  $ 32,938,711     $ 35,112,981